Leo’s Law
- Introduced Mar 27
- Committee Mar 27
- Passed House Next
- Passed Senate Not yet
- To President Not yet
- Law Not yet
Where it stands
In committee, Mar 27, 2023Next: House vote
1300d ago Apr 7, 2023: Referred to the Subcommittee on Health.
Final votes
No roll callsNo recorded vote on this bill yet
Member trades
0trades in the last 90 days
None in these companies
Who backs the bill and who pushes back Subscribe
Companies lobbying on this bill
1 companyCompanies by sector
Biotech & Pharma 1
Search all 1 companies, their asks and price moves Subscribe
Votes
No recorded roll-call vote on this bill yet
Member trades
No member of Congress traded these companies in the last 90 days
Summary
Leo's Law
Full summary1 paragraphs
This bill extends by 180 days the relevant periods of market exclusivity for drugs for rare diseases or conditions (i.e., orphan drugs) for which applications were submitted during the COVID-19 emergency period.
Library of Congress summary, Mar 27, 2023
Summary versions
- Introduced in HouseMar 27, 2023
Actions
- HouseReferred to the Subcommittee on Health.Apr 7, 2023
- HouseIntroduced in HouseMar 27, 2023
- HouseReferred to the House Committee on Energy and Commerce.Mar 27, 2023
Bill record
Text versions1
- Introduced in HouseMar 27, 2023PDF: Introduced in House
Committees1
- House Energy and Commerce CommitteeReferred To Mar 27, 2023
- Subcommittee: Health SubcommitteeReferred to
Sponsor and cosponsors2 cosponsors
- Rep. Josh Gottheimer (D-NJ-5)Sponsor, Mar 27, 2023
- Don Bacon (R-NE-2)OriginalJoined Mar 27, 2023
- Madeleine Dean (D-PA-4)Joined Jul 25, 2023
Amendments0
No amendments offered
Cost estimates and reports0
No cost estimate or committee report yet
Titles2
Short titles
- Leo’s LawShort Title(s) as Introduced
Official titles
- To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic Act for the development of orphan drugs, and for other purposes.Official Title as Introduced
Subjects1
Policy area
Related bills0
No related bills listed
Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.